anti-Adiponectin (mouse), mAb (MADI 1147)

AdipoGen Life Sciences

anti-Adiponectin (mouse), mAb (MADI 1147)

10

ImmunoPrecipitation, Western Blot, ELISA

Research Use Only

Monoclonal

MADI 1147

1 mg/ml

Adipoq

adiponectin, C1Q and collagen domain containing

30 kDa adipocyte complement-related protein; 30kDa; a; Acd; Acdc; Acr; Acrp30; Ad; Adid; adip; adipo; adipocyte complement related protein; adipocyte complement-related 30 kDa protein; adipocyte, C1Q and collagen domain containing; adipocyte, C1q and collagen domain-containing protein; adipocyte-specific protein AdipoQ; adiponectin; adiponectin d; ap; apM1; APN; GBP2; GBP28

Mouse

IgG1

Adiponectin

ACRP30 was identified as a novel adipocyte-specific synthesized and secreted protein with structural resemblance to complement factor C1q. Like adipsin, ACRP30 secretion is induced ~10-fold during adipocyte differentiation. Plasma levels are reduced in obese humans, and low levels are associated with insulin-resistance. Treatment of db/db mice with TZD increased ACRP30 levels. - Monoclonal Antibody. Recognizes mouse adiponectin. Detects a band of ~30kDa by Western blot. Weakly cross-reacts with human and rat adiponectin. Isotype: Mouse IgG1kappa. Clone: MADI 1147. Applications: ELISA, IP, WB. Liquid. 0.2microm-filtered solution in PBS, pH 7.4. Contains no preservatives. ACRP30 was identified as a novel adipocyte-specific synthesized and secreted protein with structural resemblance to complement factor C1q. Like adipsin, ACRP30 secretion is induced ~10-fold during adipocyte differentiation. Plasma levels are reduced in obese humans, and low levels are associated with insulin-resistance. Treatment of db/db mice with TZD increased ACRP30 levels.

-20°C,2°C to 8°C

12352203